Launched last week, the KTN Medicines Discovery Landscape portal provides a simple and accessible platform that shows the UK’s strengths and capabilities across the medicines discovery landscape. On the blog today, Dr Alexander Henzing from the KTN gives an overview of the portal.

Medicines discovery is evolving. Historically, discovery was mainly conducted in house, whereas currently a significant proportion of this process is external through in-licensing, outsourcing and collaborative partnerships. Medicines discovery is now firmly a multidisciplinary process whether as part of a multinational pharma or biotech company, contract research organisation or academic institution.

Knowledge Transfer Network’s (KTN) role, in this space, is principally around building a community across the medicines discovery and manufacturing sectors, where individual sector communities already exist. We also use our expertise to drive cross sector knowledge transfer and collaboration. We’re there to assist companies in navigating the innovation landscape for medicines discovery and manufacturing and finding the right way, or organisation, to help solve their challenges so that the UK is increasingly the location of choice for this type of activity. We are part of the Innovate UK family, working alongside Enterprise Europe Network (EEN), National Contact Points (NCP) and the Catapult Network. For this sector there are at least four that align well – the Cell and Gene Therapy; High Value Manufacturing; Precision Medicine and Medicines Discovery Catapult centres. Ultimately this is about accelerating innovation to grow the economy and to bring benefits to patients sooner.

MD Landscape Home Page

The KTN Medicines Discovery Landscape portal provides a simple and accessible platform that shows the UK’s strengths and capabilities across the medicines discovery landscape from the identification of novel therapeutic targets to developing products that represent substantial improvements on current treatments.

KTN Medicines Discovery Landscape was designed to map the innovation landscape in medicines discovery to showcase the UK capabilities and enable the added leverage from external collaborations from outsourcing to strategic partnerships. It complements other similar resources such as the KTN’s Medicines Manufacturing and Precision Medicine Landscape Portals.

The Medicines Manufacturing Landscape Portal was delivered by KTN on behalf of the Medicines Manufacturing Industry Partnership (MMIP). MMIP is supported by trade associations, the Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) with the KTN as a partner.

The Precision Medicine Landscape portal was delivered by Innovate UK and hosted by the KTN on behalf of the Precision Medicine Programme Coordination Group.